News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,713 Results
Type
Article (43826)
Company Profile (274)
Press Release (676613)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (208452)
Career Advice (2102)
Deals (35994)
Drug Delivery (101)
Drug Development (82467)
Employer Resources (174)
FDA (16805)
Job Trends (15181)
News (352636)
Policy (33533)
Tag
Academia (2718)
Accelerated approval (5)
Adcomms (21)
Allergies (88)
Alliances (51151)
ALS (100)
Alzheimer's disease (1420)
Antibody-drug conjugate (ADC) (136)
Approvals (16795)
Artificial intelligence (276)
Autoimmune disease (26)
Automation (16)
Bankruptcy (362)
Best Places to Work (11885)
BIOSECURE Act (19)
Biosimilars (109)
Biotechnology (197)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (296)
Cancer (2357)
Cardiovascular disease (183)
Career advice (1753)
Career pathing (31)
CAR-T (160)
Cell therapy (447)
Cervical cancer (21)
Clinical research (67041)
Collaboration (882)
Company closure (2)
Compensation (559)
Complete response letters (21)
COVID-19 (2671)
CRISPR (44)
C-suite (256)
Cystic fibrosis (103)
Data (2319)
Decentralized trials (2)
Denatured (20)
Depression (47)
Diabetes (279)
Diagnostics (6537)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (111)
Drug shortages (26)
Duchenne muscular dystrophy (96)
Earnings (87905)
Editorial (39)
Employer branding (21)
Employer resources (148)
Events (115314)
Executive appointments (751)
FDA (18184)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (793)
Gene editing (117)
Generative AI (22)
Gene therapy (323)
GLP-1 (731)
Government (4578)
Grass and pollen (4)
Guidances (150)
Healthcare (19465)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (128)
Indications (29)
Infectious disease (2817)
Inflammatory bowel disease (144)
Inflation Reduction Act (9)
Influenza (53)
Intellectual property (97)
Interviews (324)
IPO (16687)
IRA (42)
Job creations (3702)
Job search strategy (1488)
Kidney cancer (11)
Labor market (43)
Layoffs (482)
Leadership (19)
Legal (8097)
Liver cancer (78)
Lung cancer (332)
Lymphoma (160)
Machine learning (9)
Management (59)
Manufacturing (331)
MASH (73)
Medical device (13958)
Medtech (13963)
Mergers & acquisitions (19875)
Metabolic disorders (713)
Multiple sclerosis (86)
NASH (16)
Neurodegenerative disease (96)
Neuropsychiatric disorders (27)
Neuroscience (1989)
NextGen: Class of 2025 (6781)
Non-profit (4615)
Now hiring (40)
Obesity (377)
Opinion (213)
Ovarian cancer (81)
Pain (97)
Pancreatic cancer (89)
Parkinson's disease (154)
Partnered (21)
Patents (243)
Patient recruitment (116)
Peanut (48)
People (58500)
Pharmaceutical (66)
Pharmacy benefit managers (21)
Phase I (20950)
Phase II (29531)
Phase III (21946)
Pipeline (1356)
Policy (150)
Postmarket research (2606)
Preclinical (8985)
Press Release (69)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (394)
Real estate (6054)
Recruiting (66)
Regulatory (23029)
Reports (47)
Research institute (2449)
Resumes & cover letters (366)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (72)
Series A (137)
Series B (93)
Service/supplier (12)
Sickle cell disease (52)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3698)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (48)
The Weekly (31)
Vaccines (728)
Venture capitalists (42)
Weight loss (242)
Women's health (36)
Worklife (16)
Date
Last 7 days (940)
Last 30 days (3039)
Last 365 days (32855)
2025 (11855)
2024 (35799)
2023 (40808)
2022 (51978)
2021 (56630)
2020 (55199)
2019 (47979)
2018 (36147)
2017 (33123)
2016 (32602)
2015 (38725)
2014 (32437)
2013 (27611)
2012 (29799)
2011 (30434)
2010 (28426)
Location
Africa (762)
Alabama (54)
Alaska (7)
Arizona (236)
Arkansas (13)
Asia (39528)
Australia (6460)
California (6432)
Canada (2070)
China (540)
Colorado (276)
Connecticut (293)
Delaware (156)
Europe (86136)
Florida (952)
Georgia (219)
Idaho (61)
Illinois (557)
India (26)
Indiana (319)
Iowa (11)
Japan (173)
Kansas (108)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (936)
Massachusetts (4805)
Michigan (223)
Minnesota (413)
Mississippi (2)
Missouri (89)
Montana (30)
Nebraska (25)
Nevada (67)
New Hampshire (66)
New Jersey (1799)
New Mexico (29)
New York (1819)
North Carolina (1006)
North Dakota (8)
Northern California (2822)
Ohio (212)
Oklahoma (14)
Oregon (36)
Pennsylvania (1427)
Puerto Rico (13)
Rhode Island (33)
South America (1148)
South Carolina (25)
South Dakota (1)
Southern California (2421)
Tennessee (106)
Texas (950)
United States (24187)
Utah (190)
Virginia (155)
Washington D.C. (65)
Washington State (576)
West Virginia (3)
Wisconsin (56)
720,713 Results for "delcath systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Delcath Systems Reports First Quarter 2025 Results and Business Highlights
May 9, 2025
·
10 min read
Press Releases
Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 14, 2025
March 17, 2025
·
2 min read
Press Releases
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
March 24, 2025
·
2 min read
Business
Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors
Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Bridget Martell to the Company’s Board of Directors effective May 23, 2024.
May 28, 2024
·
4 min read
Press Releases
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
April 28, 2025
·
4 min read
Press Releases
Delcath Systems Reports Fourth Quarter and Full Year 2024 Results
March 6, 2025
·
11 min read
Press Releases
Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma
April 10, 2025
·
5 min read
Press Releases
Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call
February 20, 2025
·
2 min read
Business
Delcath Systems Reports First Quarter 2024 Results and Business Highlights
Delcath Systems, Inc. today reported financial results and business highlights for the first quarter ended March 31, 2024.
May 14, 2024
·
9 min read
Business
Delcath Systems to Host First Quarter 2024 Earnings Call
Delcath Systems, Inc. announced it will host a conference call on May 14, 2024, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2024.
May 7, 2024
·
2 min read
1 of 72,072
Next
